Evidence map›Paper›PMID 24454290›Full record

ReviewFrontiers in physiology2014

Connexin and pannexin (hemi)channels in the liver.

Michaël Maes, Elke Decrock, Bruno Cogliati, André G Oliveira, Pedro E Marques, Maria L Z Dagli, Gustavo B Menezes, Gregory Mennecier, Luc Leybaert, Tamara Vanhaecke and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Pannexin channels in inflammation and tumorigenesis.Frontiers in cell and developmental biology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Connexin Expression Is Altered in Liver Development ofInternational journal of molecular sciences · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Structural determinants of COCommunications biology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Michaël MaesDepartment of Toxicology, Center for Pharmaceutical Research, Vrije Universiteit Brussel Brussels, Belgium.
Elke DecrockPhysiology Group, Department of Basic Medical Sciences, Ghent University Ghent, Belgium.
Bruno CogliatiDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of Sao Paulo Sao Paulo, Brazil.
André G OliveiraDepartment of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
Pedro E MarquesDepartment of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
Maria L Z DagliDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of Sao Paulo Sao Paulo, Brazil.
Gustavo B MenezesDepartment of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
Gregory MennecierDepartment of Pathology, School of Veterinary Medicine and Animal Science, University of Sao Paulo Sao Paulo, Brazil.
Luc LeybaertPhysiology Group, Department of Basic Medical Sciences, Ghent University Ghent, Belgium.
Tamara VanhaeckeDepartment of Toxicology, Center for Pharmaceutical Research, Vrije Universiteit Brussel Brussels, Belgium.
Vera RogiersDepartment of Toxicology, Center for Pharmaceutical Research, Vrije Universiteit Brussel Brussels, Belgium.
Mathieu VinkenDepartment of Toxicology, Center for Pharmaceutical Research, Vrije Universiteit Brussel Brussels, Belgium.
Vrije Universiteit Brussel · BEUniversidade de São Paulo · BRUniversidade Federal de Minas Gerais · BRGhent University · BE

Funding

European Research Council 335476
6 · The paper itself

Abstract

The liver was among the first organs in which connexin proteins have been identified. Hepatocytes harbor connexin32 and connexin26, while non-parenchymal liver cells typically express connexin43. Connexins give rise to hemichannels, which dock with counterparts on adjacent cells to form gap junctions. Both hemichannels and gap junctions provide pathways for communication, via paracrine signaling or direct intercellular coupling, respectively. Over the years, hepatocellular gap junctions have been shown to regulate a number of liver-specific functions and to drive liver cell growth. In the last few years, it has become clear that connexin hemichannels are involved in liver cell death, particularly in hepatocyte apoptosis. This also holds true for hemichannels composed of pannexin1, a connexin-like protein recently identified in the liver. Moreover, pannexin1 hemichannels are key players in the regulation of hepatic inflammatory processes. The current paper provides a concise overview of the features of connexins, pannexins and their channels in the liver.

Indexed as

cell deathconnexingap junctionhemichannelhepatocyteinflammationpannexin

Identifiers

PMID24454290
PMCPMC3887319
OpenAlexW2164771884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.